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Macrophages expressing
uncoupling protein 1 increase
in adipose tissue in response
to cold in humans
Brian S. Finlin1,4, Hasiyet Memetimin1,4, Amy L. Confides2, Beibei Zhu1, Philip M. Westgate3,
Esther E. Dupont‑Versteegden2 & Philip A. Kern1*
Acute cold induces beige adipocyte protein marker expression in human subcutaneous white adipose
tissue (SC WAT) from both the cold treated and contralateral leg, and the immune system regulates SC
WAT beiging in mice. Cold treatment significantly increased the gene expression of the macrophage
markers CD68 and 86 in SC WAT. Therefore, we comprehensively investigated the involvement of
macrophages in SC WAT beiging in lean and obese humans by immunohistochemistry. Cold treatment
significantly increased CD163/CD68 macrophages in SC WAT from the cold treated and contralateral
legs of lean and obese subjects, and had similar effects on CD206/CD68 macrophages, whereas the
effects on CD86/CD68 macrophages were inconsistent between lean and obese. However, linear
regression analysis did not find significant relationships between the change in macrophage numbers
and the change in UCP1 protein abundance. A high percentage of CD163 macrophages in SC WAT
expressed UCP1, and these UCP1 expressing CD163 macrophages were significantly increased by cold
treatment in SC WAT of lean subjects. In conclusion, our results suggest that CD163 macrophages are
involved in some aspect of the tissue remodeling that occurs during SC WAT beiging in humans after
cold treatment, but they are likely not direct mediators of the beiging process.
Subcutaneous white adipose tissue (SC WAT) of adult humans is a dynamic tissue that is capable of undergoing
enormous expansion to store lipid during nutrient excess, or producing free fatty acids by lipolysis in response
to demand. Chronic stimulation of the sympathetic nervous system by cold or specific agonism of βadrenergic
receptors (βAR) receptors remodels SC WAT by inducing the formation of a unique type of adipocyte in white
adipose tissue that is called a beige a dipocyte1. Studies in mice have demonstrated that beige adipose has beneficial effects on metabolic homeostasis (recently reviewed2). Less is known about beige adipose in humans, but
our recent work has demonstrated that human SC WAT increased the expression of beige adipose markers in
response to cold or β3AR stimulation3, 4. In response to the β3AR agonist mirabegron, beiging occurred along
with improvement of glucose metabolism and muscle fiber type switching to type I fibers in obese research
participants3, and another study also found improved glucose metabolism after mirabegron treatment5.
Studies in mice have demonstrated a role for cells of the immune system in adipose beiging (recently
reviewed2, 6). These studies have implicated macrophages, eosinophils, iNKT cells, and type 2 innate lymphoid
cells in the process of SC WAT beiging with a number of distinct roles described for each cell type6–12. Immune
cells interact with each other and beige adipocytes, secreting numerous proteins and small molecules that regulate multiple aspects of beige adipose tissue including sympathetic tone6–16. The role that macrophages play in
SC WAT beiging in mice has been intensively studied, and these studies support the concept that alternatively
activated, anti-inflammatory macrophages increase in SC WAT in response to sympathetic nervous system
activation and are associated with beiging, whereas pro-inflammatory macrophages inhibit b eiging6, 7, 17–20. Our
recent studies on the role of immune cells in human SC WAT implicated mast cells in the seasonal regulation
of UCP1 in humans21 and in beiging in response to acute cold22. Furthermore, we observed that a subtype of
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Genea

Function

Pre counts

Pre SEM

Post counts

Post SEM

Fold change

P-value

FNDC5

Secreted factor (promotes beiging)

20

2

16

1

0.783

0.009

IL18

Cytokine

85

8

109

13

1.288

0.015

ADIPOR1

Adiponectin Receptor

2847

168

2232

163

0.784

0.020

CD68

Macrophage marker (pan)

1309

227

1646

302

1.257

0.024

TIMP2

Extracellular matrix remodeling

3475

251

3093

194

0.890

0.028

CCL18

Chemokine

703

238

1536

482

2.185

0.035

ANGPTL1

Angiogenesis regulator

345

23

282

38

0.818

0.036

F3

Secreted factor

709

58

551

61

0.777

0.042

EBF3

Brown fat marker

608

29

509

46

0.837

0.043

CD86

Macrophage marker (M1)

107

9

139

19

1.296

0.048

FGF2

Secreted factor

1289

113

1088

143

0.844

0.050

CD163

Macrophage Marker (M2)

1240

109

1639

239

1.322

0.06

Table 1.  Genes significantly regulated in SC WAT of the cold treated leg of obese research participants. a Gene
expression was measured with a custom codeset22 using the Nanostring nCounter system. The expression level
of the gene (nCounter counts) and the SEM are indicated. The fold-change in gene expression (post / pre) is
also indicated. Data were analyzed by a paired, two-tailed Student’s t-test.

alternatively activated macrophages that express CD163 and are called M2c, increased in SC WAT after treatment with mirabegron, suggesting a potential role for these alternatively activated macrophages in b
 eiging3.
In this study, we analyzed SC WAT of humans that had increased beige adipose marker expression in response
to cold4. We detected changes in the gene expression of macrophage markers in obese subjects that were treated
acutely with cold. We then comprehensively characterized SC WAT macrophages by immunohistochemistry
and examined the relationship between macrophages and SC WAT beiging.

Results

Repeated cold exposure increases macrophage marker gene expression in SC WAT.

We previously observed that repeated cold exposure (an ice pack applied to one leg for 30 min per day for 10 days)
increased the expression of three beige adipose tissue protein markers (UCP1, TMEM26, and CIDEA) in SC
WAT of both lean and obese research participants4. That study was designed to evaluate the direct effect of cold
by analyzing SC WAT from the cold treated leg, and SC WAT from the contralateral leg was studied as w
 ell4.
Interestingly, cold-induced beige adipose marker expression was equivalent in both legs, likely due to sympathetic nervous system a ctivation4. Here, we performed multiplex analysis of gene expression in the SC WAT
from the obese subjects of that study using the Nanostring nCounter system and a code set designed to measure
immune cells markers and chemokines, extracellular matrix remodeling, angiogenesis, adipokines, and important metabolic genes and transcription factors22. Results of multiplex analysis of gene expression from the lean
subjects were recently reported and identified an interesting role for mast cells in beiging22. In addition, we also
note that results of gene expression of UCP1 and TMEM26 were also reported4. Genes that were significantly
changed by acute cold exposure in SC WAT from the legs of obese subjects are shown in Tables 1 and 2. Analysis
of these two tables suggested that cold affected macrophages since the gene expression of the pan macrophage
marker CD68 and the pro-inflammatory macrophage marker CD86 was increased in SC WAT from both legs
(Tables 1 and 2). There was also a trend (P = 0.06) for an increase in gene expression of the macrophage marker
CD163 in SC WAT from both legs (Tables 1 and 2).

Repeated cold exposure changes macrophage abundance in SC WAT.

Since the analysis of gene
expression suggested that macrophage abundance in SC WAT is changed by cold, we comprehensively quantified macrophages by immunohistochemistry using three common macrophage markers. These markers (CD86,
CD163, and CD206) discriminate between pro-inflammatory (M1, CD86) and anti-inflammatory (M2, CD163
and CD206) macrophages. We note that the SC WAT was previously shown to have increased beige protein
marker expression (TMEM26 and UCP1), and that UCP1 was shown to be expressed in additional structures
besides unilocular a dipocytes4. We used co-staining of the pan macrophage marker CD68 with CD86 to identify M1 macrophages, CD68 with C206 to identify M2 macrophages, and CD68 with CD163 to identify M2c
macrophages. Representative staining of each type of macrophage is shown in Fig. 1. CD86/CD68 macrophages
increased in the contralateral leg of lean subjects, but decreased in the contralateral leg of obese subjects (Fig. 2A;
P < 0.01), and this difference in response between lean and obese subjects was highly significant (Fig. 2A; interaction P < 0.0001). Cold significantly increased CD206/CD68 macrophages in SC WAT of the cold treated leg
of both lean and obese subjects (Fig. 2B; P < 0.001), but only in the contralateral leg of lean subjects (Fig. 2B;
P < 0.05). Finally, cold significantly increased CD163/CD68 macrophages in SC WAT of the cold treated leg
and of the contralateral leg of lean and obese subjects (Fig. 2C lean: P < 0.05 (cold), P < 0.01 (contralateral),
obese: P < 0.01 (cold), P < 0.05 (contralateral)). Thus, cold treatment had the most consistent effect on increasing CD163/CD68 macrophages. Interestingly, our analysis of gene expression identified the chemokine CCL18
as being induced by approximately twofold in both legs (Tables 1 and 2). CCL18 is has been demonstrated to
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Genea

Function

Pre counts

Pre SEM

Post counts

Post SEM

Fold change

P-value

EBF3

Brown fat marker

608

29

505

30

0.830

0.003

TEK

Angiogenesis

437

31

335

21

0.767

0.003

FOXO1

Transcription regulation

1037

40

858

41

0.827

0.006

ACACA

Fatty Acid metabolism

166

15

144

15

0.870

0.007

F3

Secreted factor

709

58

534

54

0.754

0.009

FGF2

Secreted factor

1289

113

1019

75

0.791

0.012

SIRT1

Transcription regulation

467

22

422

22

0.903

0.013

BCL2

Apoptosis

617

14

489

44

0.792

0.021

ANGPT4

Angiogenesis

14

2

11

1

0.784

0.023

LEP

Adipokine

4558

793

3900

594

0.856

0.023

HMOX1

Heme metabolism

942

84

3066

781

3.255

0.036

CCL18

Chemokine

703

238

1451

411

2.065

0.037

CD86

Macrophage marker (M1)

107

9

137

16

1.287

0.041

VEGFA

Angiogenesis

810

50

925

58

1.142

0.045

LOX

Extracellular matrix

1514

87

1792

117

1.183

0.047

CD68

Macrophage marker (pan)

1309

227

1712

306

1.308

0.048

CD163

Macrophage marker (M2)

1240

109

1575

139

1.270

0.061

Table 2.  Genes significantly regulated in SC WAT of the contralateral leg of obese research participants. a Gene
expression was measured with a custom codeset22 using the Nanostring nCounter system. The expression level
of the gene (nCounter counts) and the SEM are indicated. The fold-change in gene expression (post / pre) is
also indicated. Data were analyzed by a paired, two-tailed Student’s t-test.

polarize macrophages to the M2 phenotype and to increase CD163 expression23, providing a possible additional
mechanism besides recruitment for the consistent increase in CD163/CD68 macrophages. Notably, the enzyme
heme oxygenase 1 (HMOX1), which is induced by CD163 s ignaling24, was highly increased by cold (Tables 1 and
2), consistent with the increase in CD163/CD68 macrophages.
We previously reported that mirabegron treatment of obese subjects increased CD163/68 macrophages in
SC WAT of obese subjects, but did not result in any change in CD86/68 or CD206/68 macrophage abundance in
SC WAT3. This suggests that there are differences between the response to a β3AR agonist and cold. We therefore analyzed whether the change in macrophage recruitment by cold was different from the change caused by
mirabegron. When we compared the responses of the subjects in these studies, we did not detect a significant
difference in the change in CD86/68 or CD206/CD68 macrophages (Fig. 3A and B) in the relatively small number
of subjects in each study. Similarly, the magnitude of the change in CD163/68 macrophages was similar among
the treatments (Fig. 3C), consistent with the ability of each treatment to significantly increase this subtype of
macrophage (Fig. 2C and3).
Cold increases CD163/UCP1 macrophages in SC WAT
. We recently observed that CD163 macrophages
expressed UCP1 and that CD163/UCP1 positive cells increased in SC WAT following chronic treatment with the
β3AR agonist mirabegron3. Representative images of UCP1-expressing CD163 positive cells are shown in Fig. 4.
We quantified CD163/UCP1 cells in SC WAT and found that UCP1/CD163 positive cells increase in SC WAT
from both the cold-treated and contralateral legs of lean subjects (Fig. 5A; cold lean: P < 0.01; contralateral lean:
P < 0.001). In obese subjects, the increase of CD163/UCP1 macrophages in SC WAT from the cold treated leg
was not statistically significant (P < 0.10). Approximately 75% of CD163 macrophages in lean subjects and 50%
in obese subjects expressed UCP1, but this percentage did not significantly change after cold exposure (Fig. 6).
Thus, the increase in CD163/UCP1 macrophages is due mostly to the increase in recruitment and/or phenotype
switching to CD163 macrophages (Fig. 2C). Next, we examined UCP1/CD206 macrophages and found that they
were only significantly increased in the contralateral leg (Fig. 5B; P < 0.05) with a trend for an increase in the
cold treated leg of lean subjects. However, there was a trend for CD206/UCP1 macrophages being lower in the
contralateral leg of obese subjects after cold (Fig. 5B; P < 0.1), and this different response between lean and obese
in the contralateral legs was significant (P < 0.0001).
Macrophage recruitment does not predict the level of SC WAT beiging. We have recently characterized beiging in
this cohort of lean and obese research participants in response to cold4. Some studies in mice have suggested that
macrophages are direct mediators of beiging, perhaps as a source of catecholamine7, although this was recently
disputed12. If macrophages are direct mediators of beiging, one would expect that subjects in which more macrophages were recruited to SC WAT would display a higher degree of beiging. We investigated this by performing a linear regression analysis of the change in UCP1 expression versus the change in macrophages in SC WAT
from each leg. Overall there was little correlation (Table 3), suggesting that macrophages are recruited to adipose
tissue for other purposes such as tissue remodeling, regulating local free fatty acid levels, or other putative roles
suggested by rodent studies6. We also investigated whether the change in CD163 macrophages expressing UCP1

Scientific Reports |

(2021) 11:23598 |

https://doi.org/10.1038/s41598-021-03014-3

3
Vol.:(0123456789)

www.nature.com/scientificreports/

Figure 1.  Representative images of macrophage immunohistochemistry. Human SC WAT was co-stained
with antibodies against CD163 and CD68 (A), CD206 and CD68 (B), or CD86 and CD68 (C) before and after
cold treatment as indicated. Fluorescence in each individual channel is presented followed by a merged image.
Arrows indicate cells that co-stain with each specific macrophage antibody, CD68 (red), and that are DAPI
positive (blue). Scale bars: 10 µm.

correlated with the change (increase) in UCP1 activity using bioenergetics data available from five of the lean
subjects4, but did not find a significant correlation (P = 0.42). Finally, we performed regression analyses of the
change in CD163 macrophages versus the change in the expression of several genes important for adipose function, such as adiponectin, PPARγ, and others, but did not observe any significant correlations (Table 4).
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Figure 2.  Quantification of inflammatory and anti-inflammatory macrophages in SC WAT of research
participants in response to acute cold treatment. (A) to (C) Quantification of CD86/68, CD206/68, and
CD163/68 positive macrophages in lean (n = 15–17) and obese (n = 8) research participants at baseline and in SC
WAT from the cold and contralateral legs after 10 days of acute cold exposure. Data represent means ± SEM and
were analyzed by RM MANOVA as described in research design and methods. *P < 0.05; **P < 0.01; ***P < 0.001;
****P < 0.0001 (lean n = 17; obese n = 8).

Discussion

This study demonstrated that anti-inflammatory (M2) macrophages, especially those expressing CD163, are
recruited to SC WAT in both lean and obese subjects in response to cold. This observation is consistent with
our recent finding that CD163 macrophages are increased in SC WAT by mirabegron treatment3, suggesting an
important role for CD163 macrophages in SC WAT beiging induced by a specific β3AR agonist. A number of roles
for macrophages has been proposed in tissue remodeling that occurs in response to cold, including macrophages
being a source of catecholamine and direct mediators of b
 eiging7, although this was recently d
 isputed12. We did
not observe significant correlation of increased CD163 macrophages with the increase in UCP1 protein expression, which was previously documented4, suggesting that macrophages are not direct mediators of beiging. This
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Figure 3.  Analysis of the change in inflammatory and anti-inflammatory macrophages in SC WAT of
obese research participants in response to mirabegron and acute cold treatment. The change (post–pre)
in macrophages in SC WAT was calculated for obese subjects treated with cold or for subjects treated with
mirabegron using previous published d
 ata3. (A) to (C) Analysis of the change in CD86/68, CD206/68, and
CD163/68 positive macrophages in response to mirabegron (n = 13) or cold (n = 8). Data represent means ± SEM
and were analyzed by ANOVA as described in research design and methods. *P < 0.05; **P < 0.01; ***P < 0.001;
****P < 0.0001 (lean n = 17; obese n = 8).

finding is similar to a recent study in m
 ice17, suggesting that M2 macrophages are involved in other aspects of
the changes that occur in SC WAT response to sympathetic nervous system activation such as tissue remodeling.
The role of macrophages in adipose tissue under different physiological settings such as obesity has been
widely studied25, 26. Macrophages are key mediators of low grade adipose tissue inflammation in obesity, promoting insulin resistance26. Recent work indicates that adipose tissue inflammation also inhibits the formation of
beige adipose and that M2 macrophages have numerous roles in beige adipose tissue (reviewed in6). The recruitment of anti-inflammatory macrophages, in particular CD163/CD68 positive macrophages, by cold could thus
promote beiging by reducing SC WAT inflammation or additional mechanisms such as beige adipogenesis27, 28.
There have been a limited number of studies on the effect of βAR agonism on SC WAT macrophages in humans3.
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Figure 4.  Representative images of UCP1 and CD163 co-staining. (A) Human SC WAT was co-stained with
UCP1 and CD163 antibodies before and after cold treatment as indicated. Fluorescence in each individual
channel is presented followed by a merged image. Arrows indicate cells that co-stain with UCP1 (red) and
CD163 (green), and that are DAPI positive (blue). (B) and (C) No primary antibody controls for the co-staining
are presented. Scale bars: 10 µm.

The current study illustrates that cold has complicated effects on SC WAT macrophage abundance that depend
on whether the subject is lean or obese and the type of macrophage being studied. The decrease of CD86/CD68
macrophages and increase of anti-inflammatory macrophages is predicted to reduce SC WAT inflammation, and
determining whether acute cold improves adipose tissue function and/or metabolic homeostasis is an important
goal for future studies.
CD163 macrophages were consistently increased in SC WAT by cold in parallel with increased beiging herein
and in our previous study with the β3AR agonist mirabegron3, suggesting an important role for this type of
macrophage in adipose beiging. One possible clue to the role of CD163 macrophages is the significant number
co-expressing UCP1. CD163 macrophages may themselves be thermogenic, but the relatively low abundance
of these macrophages does not make it likely that they make a substantial contribution to thermogenesis. Macrophages have been shown to increase in SC WAT in order to regulate local free fatty acid levels in response
to lipolytic stimuli by taking up lipid29; increased uncoupled respiration would allow macrophages to oxidize
some of the lipid to facilitate this process. The role of UCP1 in CD163 macrophages will thus require further
investigation. Another possible role for the increase in CD163 macrophages role is suggested by CD163 itself.
CD163 is the receptor for hemoglobin, and CD163 macrophages are known to be involved in iron h
 omeostasis30,
which is important in adipose beiging31. Interestingly, HMOX is regulated by CD163 engagement and was highly
induced in SC WAT by cold (Tables 1 and 2), suggesting a possible regulatory role in iron metabolism during
SC WAT beiging.
In conclusion, the results of this study suggest that cold significantly increases the abundance of CD163
macrophages in SC WAT. This increase is accompanied by increased beiging, and is consistent with our recent
observation that the β3AR agonist mirabegron increased CD163 macrophage abundance in SC WAT and SC
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Figure 5.  Quantification of UCP1 positive macrophages in SC WAT of research participants in response to
acute cold treatment. (A) and (B) Quantification of CD163/UCP1 and CD206/UCP1positive macrophages in
lean (n = 17) and obese (n = 8) research participants at baseline and in SC WAT from the cold and contralateral
legs after 10 days of acute cold exposure. Data represent means ± SEM and were analyzed by RM MANOVA as
described in research design and methods. *P < 0.05; **P < 0.01; ***P < 0.001; #P < 0.1 (lean n = 17; obese n = 8).

WAT beiging3. Identifying the role that CD163 expressing macrophages play in response to βAR agonism will
require future investigation.

Research design and methods

Human subjects and study design. The baseline characteristics and additional details about the research

participants have been described elsewhere4. The study was performed in subjects recruited in summer (between
June 15 and September 1). SC WAT biopsies were obtained at baseline and after a cold pack was applied to the
thigh 30 min per day for 10 days. Both the cold treated leg and the contralateral leg were biopsied after treatment. The change in UCP1 protein expression was calculated using previously published d
 ata4. All subjects
gave informed consent, and the protocols were approved by the Institutional Review Board at the University of
Kentucky. All experiments were performed in accordance with relevant guidelines and regulations. The Clinicaltrials.gov registration identifiers are NCT02596776 (date of registration: 11/04/2015) and NCT02919176 (date
of registration 9/29/2016).

mRNA quantification. We used the Nanostring ncounter multiplex system to measure the expression of

130 genes and six housekeeping genes in purified RNA from SC WAT of subjects with obesity in which we demonstrated beiging in response to cold4. Briefly, RNA was purified using RNAeasy Lipid Tissue minikits (Qiagen,
Valencia, CA) and analyzed using an Agilent 2100 bioanalyzer. Gene expression was normalized to the geometric mean of the six housekeeping genes according to the manufacturer’s instructions. The genes in the code set
are described in references22, 32.

Immunohistochemistry.

Immunohistochemistry on SC WAT sections was performed as described
 reviously22. Briefly, paraffin embedded adipose sections were deparaffinized followed by antigen retrieval in
p
10 mM sodium citrate pH 6.5 at 92 °C. For CD206/CD68 macrophage staining, sections were blocked with
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Figure 6.  Quantification of the percentage of CD163 macrophages that express UCP1 in response to acute cold
treatment. The percentage of CD163 macrophages that express UCP1 before and after cold is indicated. Data
represent means ± SEM.

Macrophage type

Leg

r2

P-valuea

Lean research participants
CD206/CD68

Cold

0.026

0.56

CD206/CD68

Contralateral

0.330

0.02b

CD163/CD68

Cold

0.106

0.20

CD163/CD68

Contralateral

0.002

0.87

CD86/CD68

Cold

CD86/CD68

Contralateral

< 0.0001 0.99
0.076

0.28

Obese research participants
CD206/CD68

Cold

0.033

0.67

CD206/CD68

Contralateral

0.117

0.41

CD163/CD68

Cold

0.204

0.26

CD163/CD68

Contralateral

0.002

0.91

CD86/CD68

Cold

0.066

0.54

CD86/CD68

Contralateral

0.028

0.69

Table 3.  Linear regression analysis of the change in macrophages and change in UCP1. a Linear regression
analysis was performed on the change in macrophages (post–pre) versus the change in UCP1. The change in
UCP1 was calculated from previously published data4. bP < 0.05.
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Genea

Leg

r2

P-valueb

Lean research participants
Adiponectin

Cold

0.006

0.81

Adiponectin

Contralateral

0.004

0.85

PPARγ1

Cold

0.10

0.31

PPARγ1

Contralateral

0.006

0.81

PPARγ2

Cold

0.13

0.26

PPARγ2

Contralateral

0.05

0.50

Fatty Acid Synthase

Cold

0.05

0.50

Fatty Acid Synthase

Contralateral

0.07

0.42

Leptin

Cold

0.17

0.18

Leptin

Contralateral

0.21

0.13

FABP4

Cold

0.24

0.10

FABP4

Contralateral

0.03

0.60

PGC1α

Cold

0.04

0.53

PGC1α

Contralateral

0.05

0.50

Obese research participants
Adiponectin

Cold

0.03

0.69

Adiponectin

Contralateral

0.13

0.38

PPARγ1

Cold

0.10

0.44

PPARγ1

Contralateral

0.30

0.16

PPARγ2

Cold

0.01

0.78

PPARγ2

Contralateral

0.05

0.59

Fatty Acid Synthase

Cold

0.003

0.90

Fatty Acid Synthase

Contralateral

0.07

0.51

Leptin

Cold

0.01

0.82

Leptin

Contralateral

0.01

0.78

FABP4

Cold

0.22

0.24

FABP4

Contralateral

0.29

0.17

PGC1α

Cold

0.23

0.23

PGC1α

Contralateral

0.15

0.34

Table 4.  Linear regression analysis of the change in CD163/CD68 macrophages and change gene expression.
a
Linear regression analysis was performed on the change in CD163/CD68 macrophages (post–pre) versus the
change in the expression of the indicated gene.

3% hydrogen peroxide, the streptavidin/biotin blocking kit (Vector #SP-2002), and then 2.5% normal horse
serum. Phosphate buffered saline (PBS) was used as the antibody diluent. 2.5% normal goat serum was used as a
blocking agent between primary antibodies. For all other co-staining, 2.5% horse serum was used for blocking,
1% horse serum was used as the antibody diluent for the first primary antibody, 5% horse serum was used for
blocking between the first and subsequent primary antibodies, and 1% horse serum was used as the antibody
diluent for the subsequent primary antibody. Secondary antibodies used were biotinylated donkey anti-rabbit
(Jackson ImmunoResearch, 711–065-152), goat anti-mouse biotinylated (Jackson ImmunoResearch, 115–065205), donkey anti-goat biotinylated (Jackson ImmunoResearch, 705–065-147), or goat anti-rabbit biotinylated
(Jackson ImmunoResearch, 111–065-045). Slides were incubated with strepavidin-HRP (#S911, Life Technologies, Carlsbad, CA), and then AlexaFluor 488 or 594 tyramide reagent (#B40957, Invitrogen, Carlsbad, CA) to
visualize antibody binding. Sections were mounted in Vectashield with DAPI (H1200; Vector Laboratories).
Macrophages were identified in SC WAT as DAPI positive cells that co-stained with CD68, which was used as
a pan macrophage marker, and the indicated macrophage marker. The primary antibody combinations used
for co-staining were as follows: CD206/CD68 (R&D systems AF2534; Dako #M0814), CD86/CD68 (Abcam,
ab53004; Abcam, ab955), CD163/CD68 (Abcam, ab182422, Abcam, ab955), CD163/UCP1 (Hycult, HM2157,
ECM Biosciences, J2648), CD206/UCP1 (R&D systems, AF2534, ECM Biosciences, J2648). Slides were analyzed
with a Zeiss AxioImager MI upright fluorescent microscope (Zeiss, Gottingen, Germany) and Zen software
(Zeiss).

Statistics. Paired student’s two-tailed t-tests on gene expression, one-way ANOVAs, and linear regression analyses were performed in Graphpad prism. Repeated measures multivariate analysis of variance (RM
MANOVA) was performed as d
 escribed4 to analyze macrophage recruitment using SAS version 9.4. Immunohistochemistry was performed in a blinded manner.
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Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding
author on reasonable request.
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